A5391: A study to see if a new HIV treatment regimen can reduce weight or slow weight gain
Enrollment Status: Open
A5359: A study to evaluate the efficacy, safety, and durability of long-acting ART for maintaining HIV suppression in indivudals who have trouble adhering to daily oral ART
A5368: A study to evaluate the safety and immunotherapeutic activity of a new strategy to cure Hepatitis B
A5379: A study to evaluate the safety and response to a new hepatitis B vaccine in adults with HIV
A5321: A study to evaluate the differences and changes over time in groups of HIV infected cells that ’hide’ from anti-HIV medications
A5386: An HIV "cure" study to evaluate the safety, tolerability, and efficacy of an IL-15 superagonist for controlling HIV
A5377: A study to evaluate trhe safety, tolerability, pharmacokinetics, and antivial activity of a broadly neutralizing antibody in adults with HIV
A5401/ACTIV-2: A study to evaluate the safety and efficacy of investigational agents that could modifying the immune response to SARS-CoV-2 infection or limit disease progression
IMPOWER-24: A study to evaluate the safety and efficacy of islatravir as once-a-month oral PrEP in men and transgender women who have sex with men
